Vascular Age in Patients Admitted for Coronary Syndrome with ST Segment Elevation

Junior Rocyr Ibara-Onguema *

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

Khaoula Bourzeg

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

Rim Zerhoudi

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

Mohamed El Jamili

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

Saloua El Karimi

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

Mustapha El Hattaoui

Cardiology Department, Mohammed VI University Hospital, Marrakesh, Morocco.

*Author to whom correspondence should be addressed.


Background: Vascular age is an emerging health indicator and predictor of vital organ damage (heart, brain, and kidneys). Arterial stiffness is the most widely used measure for predicting vascular aging status. For a very long time, specific risk calculation algorithms were used for each cardiovascular disease, but they were not used to approximate vascular age and therefore to give an idea of the risk of all cardiovascular complications. A review of all epidemiological studies is therefore necessary to allow a global and multimodal evaluation of the different determinants of vascular age and the association of vascular aging with cardiovascular events.

Methods and Results: We are conducting a retrospective descriptive and analytical study of 284 patients admitted to the cardiology department for ST elevation myocardial infarction (STEMI). The mean chronological age of our patients was 60,89 years, while the vascular age was much higher, up to 75 years. The vascular age of STEMI patients is 14 years higher than the chronological age. The definition of the early vascular age, normal Vascular age (VA) and Supernova profiles was based on the calculation of the difference between chronological age and vascular age, then the different clinical and paraclinical parameters of the 3 categories were studied allowing to conclude after a multivariate analysis that: diabetes (OR=9.25, [3.52; 24.36], p <0.0001) and smoking (OR=12.01, [4.56; 31.62], p<0.0001) were associated with higher rates of EVA, while hypertension (OR=1.35, [0.58; 3.1], p = 0.485) is a neutral factor. Also, age (OR=1.23, [1.11;1.38], p= 0.0002), age range between 40 and 54 years old (OR=42.53, [7.04; 256.82], p <0.0001) promotes the EVA phenotype while advanced age is a confounding factor. regarding gender, female (OR=0.35, [0.13; 0.96], p= 0.041) is a protective factor.

From this analytical study we observe that there is a large difference between chronological and vascular age. This is due to the interaction between the different risk factors and each one potentiates the other. More the patient has risk factors, the more his vessels are sick and the more he risks having fatal events. And this has an impact on the overall management of the patient.

Keywords: Chronological age, vascular age, cardiovascular risk factors, cardiovascular diseases, early vascular age, SUPERNOVA

How to Cite

Ibara-Onguema , J. R., Bourzeg, K., Zerhoudi, R., Jamili, M. E., Karimi, S. E., & Hattaoui, M. E. (2023). Vascular Age in Patients Admitted for Coronary Syndrome with ST Segment Elevation. Asian Journal of Cardiology Research, 6(1), 159–166. Retrieved from


Download data is not yet available.


Pucci G, Verdecchia P. Chronological age and vascular age staring at each other on the ring of cardiovascular prevention. Int J Cardiol Hypertens. 2021;8:100076.

Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular fibrosis in aging and hypertension: Molecular mechanisms and clinical implications. Can J Cardiol. 2016;32:659–68.

Kucharska-Newton AM, Stoner L, Meyer ML. Determinants of vascular age: An epidemiological perspective. Clin Chim. 2019;65(1): 108–118.

Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation. 2002;105:310 –315.

Zhang XF, Attia J, D’Este C, Yu XH, Wu XG. A risk score predicted coronary heart disease and stroke in a Chinese cohort. J Clin Epidemiol. 2005;58:951–958.

D'Agostino RB, Vasan RS, Pencina MJ. General Cardiovascular risk profile for use in primary care: the framingham heart study. Circulation. 2008;117:743-753.

Groenewegen KA, den Ruijter HM, Pasterkamp G, et al. Vascular age to determine cardiovascular disease risk: a sys tematic review of its concepts, definitions, and clinical applications. Eur J Prev Cardiol. 2016;23:264–274.

Bruno RM, Nilsson PM, Engström G, et al. Early and supernormal vascular aging. Hypertension. 2020;76:1616-1624.

Di Pilla M, Bruno RM, Taddei S, et al. Gender differences in the relationships between psychosocial factors and hypertension. Maturitas. 2016;93:58– 64.

Gottsäter M, Östling G, Persson M, et al. non-hemodynamic predictors of arterial stiffness after 17 years of follow-up: the malmö diet and cancer study. J Hypertens. 2015;33:957–965.

Nanna MG, Navar AM, Wojdyla D, et al. The association between low-density lipoprotein cholesterol and incident atherosclerotic cardiovascular disease in older adults: results from the national institutes of health pooled cohorts. J Am Geriatr Soc. 2019;67:2560–2567.

Neeland IJ, Das SR, Simon DN, et al. The obesity paradox, extreme obesity, and long term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR. Eur Heart J Qual Care Clin Outcomes. 2017;3:183–191.